Sawgrass Asset Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$357K Hold
635
0.05% 144
2025
Q4
$430K Hold
635
0.05% 138
2025
Q3
$406K Hold
635
0.05% 144
2025
Q2
$341K Hold
635
0.04% 143
2025
Q1
$267K Hold
635
0.03% 153
2024
Q4
$263K Hold
635
0.03% 152
2024
Q3
$321K Hold
635
0.03% 149
2024
Q2
$309K Hold
635
0.03% 155
2024
Q1
$343K Sell
635
-5
-0.8% -$2.73K 0.04% 156
2023
Q4
$355K Sell
640
-47
-7% -$22.1K 0.04% 155
2023
Q3
$300K Buy
687
+24
+4% +$12K 0.04% 168
2023
Q2
$333K Buy
+663
New +$318K 0.04% 147

Other funds holding IDXX

Sawgrass Asset Management's IDXX Position: Q1 2026 in Review

Sawgrass Asset Management held its Idexx Laboratories (IDXX) position steady in Q1 2026 at 635 shares worth $357K. The position accounts for 0.05% of the portfolio, ranked #144.

Sawgrass Asset Management first reported a position in IDXX in Q2 2023 and has held it in 12 quarters since. The position peaked at $430K in Q4 2025. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Sawgrass Asset Management held 635 shares of Idexx Laboratories worth $357K as of Q1 2026.
  • Sawgrass Asset Management left its Idexx Laboratories share count unchanged in Q1 2026.
  • Idexx Laboratories made up 0.05% of Sawgrass Asset Management's portfolio in Q1 2026, its #144 holding.
  • Sawgrass Asset Management first reported a position in Idexx Laboratories in Q2 2023 and has held it in 12 quarters since.
  • Sawgrass Asset Management's Idexx Laboratories position peaked at $430K in Q4 2025.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Sawgrass Asset Management's 13F filing for Q1 2026, filed 1 May 2026.